Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of August 2025, specifically reporting on the closing of a previously announced rights offering. The subscription period expired on July 28, 2025, and the offering officially closed on August 1, 2025, following reconciliation with The Depositary Trust Company.
Key Financial Metrics
- Gross Proceeds: The Company received $9,999,989.33 in gross proceeds from the rights offering.
- Securities Issued:
- 9,954,756 Ordinary Shares
- Warrants to purchase 9,999,994 Ordinary Shares
- 45,238 Pre-Funded Warrants
- Subscription Price: $1.00 per unit (one Ordinary Share and one Warrant) and $0.9999 per unit (one Warrant and one Pre-Funded Warrant).
- Debt Repayment Plan: Proceeds are designated to repay a bridge loan from Epoch Partner Investments Limited.
The filing text does not provide clear values for revenue, profit, operating cash flow, margins, or total liquidity positions outside of the proceeds from this specific transaction.
Material Changes
The primary material change is the successful completion of a rights offering that was approximately two times over-subscribed. The offering included both basic subscription rights and an over-subscription privilege, resulting in the issuance of nearly 10 million new ordinary shares and a corresponding number of warrants. Unexercised subscription rights expired and became void upon closing.
Guidance, Outlook, and Risks
Use of Proceeds: Management expects to use the funds to repay the Epoch bridge loan and for general corporate and working capital purposes.
Risks and Contingencies: The filing includes standard forward-looking statement disclaimers. Specific risks identified include:
- Uncertainty regarding future clinical trial results and scientific research.
- Dependence on available cash and the ability to obtain additional funding.
- Legal and regulatory developments in the U.S. and other jurisdictions.
- Political, economic, and military instability in the Middle East, specifically in Israel.
- Ability to maintain intellectual property rights and partner relationships.
Investor Verification Checklist
- Verify the exact amount of the bridge loan from Epoch Partner Investments Limited to confirm if the $10 million proceeds are sufficient for full repayment.
- Review the Company's current cash balance and burn rate to assess the runway provided by the new working capital.
- Confirm the dilution impact of the 9.95 million new shares and 9.99 million warrants on existing shareholders.
- Check for any updated risk factors regarding the geopolitical situation in Israel that may affect operations.